You have 1 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RNA Vaccine

Showing 26 - 50 of 9,751
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Host Immune Response to Novel RNA COVID-19 Vaccination

Recruiting
  • COVID-19 Vaccine
  • Cancer
  • COVID-19 Vaccine
  • San Antonio, Texas
    Mays Cancer Center, UT Health San Antonio
Apr 22, 2022

Influenza, Human Trial in United States (PF-07852352 Influenza saRNA 1, PF-07836391 Influenza saRNA, PF-07836394 Influenza

Recruiting
  • Influenza, Human
  • PF-07852352 Influenza saRNA 1
  • +10 more
  • Phoenix, Arizona
  • +23 more
Jan 17, 2023

Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in

Active, not recruiting
  • SARS-CoV-2 RNA Vaccines
  • HIV Infection
  • SARS-CoV-2 Vaccine
  • Sevilla, Spain
    Virgen del Rocio University Hospital
Dec 1, 2022

COVID-19, SARS-CoV-2 Infection, Corona Virus Infection Trial in Wichita, Kansas City, Singapore (ARCT-165, ARCT-154, ARCT-021)

Recruiting
  • COVID-19
  • +2 more
  • ARCT-165
  • +2 more
  • Wichita, Kansas
  • +2 more
Nov 10, 2021

SARS-CoV-2 Infection, COVID-19 Trial (BNT162b5 Bivalent or BNT162b2 Bivalent 30 µg, BNT162b4 5 µg, BNT162b4 10 µg)

Not yet recruiting
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b5 Bivalent or BNT162b2 Bivalent 30 µg
  • +3 more
  • (no location specified)
Sep 14, 2022

Melanoma, Uveal Metastatic Trial in Erlangen (Vaccination with IKKb matured Dendritic Cells)

Active, not recruiting
  • Melanoma, Uveal Metastatic
  • Vaccination with IKKb matured Dendritic Cells
  • Erlangen, Bavaria, Germany
    University Hospital Erlangen Dept. of Dermatology
Mar 16, 2022

Healthy Adult Volunteers Trial in Taipei City (ChAdOx1-nCov-19 (Astra-Zeneca), SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine)

Completed
  • Healthy Adult Volunteers
  • ChAdOx1-nCov-19 (Astra-Zeneca)
  • SARS-CoV-2 messenger RNA-1273 (Moderna) vaccine
  • Taipei City, X, Taiwan
    National Taiwan University Hospital
Oct 16, 2022

Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Pemphigus Vulgaris Trial in United States (Moderna mRNA-1273,

Recruiting
  • Rheumatoid Arthritis
  • +8 more
  • Moderna mRNA-1273
  • +5 more
  • Los Angeles, California
  • +24 more
Aug 17, 2022

COVID-19, Corona Virus Infection Trial in Ann Arbor (Pfizer-BioNTech mRNA COVID-19 vaccine, Moderna mRNA COVID-19 vaccine)

Recruiting
  • COVID-19
  • Corona Virus Infection
  • Pfizer-BioNTech mRNA COVID-19 vaccine
  • Moderna mRNA COVID-19 vaccine
  • Ann Arbor, Michigan
    University of Michigan
Apr 23, 2022

SARS-CoV2 Infection Trial in Renton (HDT-301)

Active, not recruiting
  • SARS-CoV2 Infection
  • HDT-301
  • Renton, Washington
    Rainier Clinical Research
Jan 16, 2023

Covid19, SARS-CoV Infection, Corona Virus Infection Trial in Singapore, United States (ARCT-021 single dose priming, ARCT-021

Terminated
  • Covid19
  • +2 more
  • ARCT-021 single dose priming
  • +5 more
  • Chandler, Arizona
  • +14 more
Jul 7, 2022

SARS-CoV-2 Virus, Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19 Trial (Bivalent BNT162b2 (original/Omicron

Not yet recruiting
  • SARS-CoV-2 Virus
  • +2 more
  • Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose
  • +4 more
  • (no location specified)
Sep 14, 2022

Influenza, Human, Influenza in Birds, Respiratory Tract Infections Trial in United States (aH5N6c on Day 1, aH5N6c on Day 22,

Recruiting
  • Influenza, Human
  • +7 more
  • aH5N6c on Day 1
  • +2 more
  • Huntsville, Alabama
  • +17 more
Jul 26, 2022

SARS-CoV-2 Infection, COVID-19 Trial in United States (BNT162b2, BNT162b2.B.1.351)

Completed
  • SARS-CoV-2 Infection
  • COVID-19
  • BNT162b2
  • BNT162b2.B.1.351
  • Oakland, California
  • +16 more
Feb 17, 2022

Rabies, Communicable Disease, Virus Diseases Trial in Kunming (SYN023, HRIG, Rabies Vaccine)

Active, not recruiting
  • Rabies
  • +5 more
  • SYN023
  • +2 more
  • Kunming, China
    Yunnan Province Center for Disease Control and Prevention (CDC)
Sep 23, 2021

Influenza, Human Trial in United States (Quadrivalent influenza modRNA vaccine, Quadrivalent influenza vaccine)

Recruiting
  • Influenza, Human
  • Quadrivalent influenza modRNA vaccine
  • Quadrivalent influenza vaccine
  • Athens, Alabama
  • +92 more
Sep 15, 2022

Glioblastoma Multiforme, Glioblastoma, Malignant Glioma Trial in Gainesville, Orlando, Durham (pp65-shLAMP DC with GM-CSF,

Recruiting
  • Glioblastoma Multiforme
  • +4 more
  • pp65-shLAMP DC with GM-CSF
  • +4 more
  • Gainesville, Florida
  • +2 more
Jan 6, 2022

SARS-CoV-2 Infection, COVID-19 Trial in Worldwide (Biological/Vaccine: BNT162b2 10mcg, BNT162b2 20mcg, BNT162b2 30mcg)

Active, not recruiting
  • SARS-CoV-2 Infection, COVID-19
  • Biological/Vaccine: BNT162b2 10mcg
  • +4 more
  • Birmingham, Alabama
  • +134 more
Jan 23, 2023

Influenza, Human Trial in United States (mIRV, bIRV AB, qIRV)

Recruiting
  • Influenza, Human
  • mIRV
  • +5 more
  • Athens, Alabama
  • +97 more
Aug 16, 2022

Encephalitis, Encephalitis, Viral, Infectious Encephalitis Trial in Plymouth (Vaccinations on Day 0, Day 28, and Day 140)

Unknown status
  • Encephalitis
  • +16 more
  • Vaccinations on Day 0, Day 28, and Day 140
  • Plymouth, Michigan
    SRI Biosciences Clinical Trials Unit
Feb 19, 2021

Zika Virus, Zika Virus Infection, Virus Diseases Trial in Worldwide (VRC-ZKADNA090-00-VP, VRC-PBSPLA043-00-VP)

Completed
Has Results
  • Zika Virus
  • +6 more
  • VRC-ZKADNA090-00-VP
  • VRC-PBSPLA043-00-VP
  • Miami, Florida
  • +16 more
Apr 30, 2021

Malignant Tumors Brain Trial in Durham (RNA-loaded dendritic cell vaccine, basiliximab)

Completed
  • Malignant Neoplasms Brain
  • Durham, North Carolina
    Duke University Medical Center
Mar 8, 2021

Melanoma, Colon Cancer, Gastrointestinal Cancer Trial run by the NCI (National Cancer Institute (NCI)-4650, a messenger

Terminated
Has Results
  • Melanoma
  • +4 more
  • National Cancer Institute (NCI)-4650, a messenger ribonucleic acid (mRNA)-based, Personalized Cancer Vaccine
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
May 22, 2020

Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases Trial in Miami (Low dose of quadrivalent VLP vaccine, Medium

Completed
  • Virus Diseases
  • +3 more
  • Low dose of quadrivalent VLP vaccine
  • +3 more
  • Miami, Florida
    Miami Research Associates
Jun 8, 2020

Virus Diseases, RNA Virus Infections, Respiratory Tract Diseases Trial in Toronto, Pierrefonds (Low dose of H5 VLP vaccine +

Completed
  • Virus Diseases
  • +3 more
  • Low dose of H5 VLP vaccine + Alhydrogel
  • +5 more
  • Toronto, Ontario, Canada
  • +1 more
Jun 8, 2020